ASRT
Assertio Therapeutics Inc
NASDAQ: ASRT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$18.43
+2.11% today
Updated 2026-04-30
Market cap
$116.45M
P/E ratio
—
P/S ratio
0.98x
EPS (TTM)
$-4.74
Dividend yield
—
52W range
$9 – $20
Volume
0.2M
Assertio Therapeutics Inc (ASRT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-27.70M | $14.66M | $3.35M | $1.84M | $-2.38M | $57.65M | $-30.98M | $9.75M | $-55.92M | $143.89M | $65.50M | $62.17M | $72.50M | $90.47M | $-65.57M | $5.52M | $78.60M | $49.60M | $26.41M | $-28.18M |
| Capital expenditures | $774224.00 | $156000.00 | $257000.00 | $629000.00 | $179000.00 | $698000.00 | $6.88M | $1.96M | $599000.00 | $26.71M | $2.86M | $666000.00 | $5.51M | $1.48M | $10000.00 | $53000.00 | $274000.00 | $628000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $2.45M | $2.66M | $2.03M | $3.87M | $5.07M | $6.11M | $8.93M | $14.23M | $17.17M | $13.02M | $12.59M | $10.60M | $10.92M | $3.54M | $7.50M | $9.16M | $5.01M | $3.45M |
| Free cash flow | $-28.47M | $14.51M | $3.09M | $1.21M | $-2.56M | $56.95M | $-37.87M | $7.79M | $-56.52M | $117.18M | $62.64M | $61.50M | $66.99M | $88.99M | $-65.58M | $5.47M | $78.32M | $48.98M | $26.41M | $-28.18M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | $193000.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $1.52M | $5.03M | $215.60M | $243.99M | $-387.58M | $16.63M | $9.18M | $-15.94M | $-68.84M | — | — | — | — | — | — |